PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Losartan attenuated lipopolysaccharide-induced lung injury by suppression of lectin-like oxidized low-density lipoprotein receptor-1.

Rat / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26884836 ↗2015Reported benefit

Losartan attenuated lipopolysaccharide-induced lung injury by suppression of lectin-like oxidized low-density lipoprotein receptor-1.

RatEndotoxin/LPSSprague-DawleyMalen = 30 male Sprague-Dawley rats randomised across three groups

Model: Lipopolysaccharide-induced acute lung injury

Losartan significantly reduced the lipopolysaccharide-induced rise in bronchoalveolar lavage TNF-alpha and protein, lung myeloperoxidase activity, pulmonary oedema and lung injury score, and lowered LOX-1 mRNA and protein along with the LOX-1 mediated increases in caspase-3 and ICAM-1.

Extraction: extract · Supplied extraction confidence: 0.82. Machine-extracted fields require source verification.